Phospho-Estrogen Receptor α (Ser167) Antibody (Rabbit mAb) [D20F17]

Catalog No.: F8636

    Application: Reactivity:
    • Lane 1: MCF7, Lane 2: MCF7 (hEGF, 100ng/ml, 15 min)
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:800
    Application
    WB, IF
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    66 kDa
    ポジティブコントロール MCF7 cells (hEGF, 100ng/ml, 15 min)
    ネガティブコントロール MCF7 cells (serum-starved)

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
    IF
    Experimental Protocol:
     
    Sample Preparation
    1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
    2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
    3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
    4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
     
    Fixation
    1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
    2. Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Permeabilization
    1.Add a detergent such as 0.1–0.3% Triton X-100 to the sample and incubate at room temperature for 10–20 minutes.
    (Note: This step is only required for intracellular antigens. For antigens expressed on the cell membrane, this step is unnecessary.)
    Wash the sample with PBS for 3 times, 3 minutes each time.
     
    Blocking
    Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
    Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
     
    Immunofluorescence Staining (Day 1)
    1. Remove the blocking solution and add the diluted primary antibody.
    2. Incubate the sample in a humidified chamber at 4°C overnight.
     
    Immunofluorescence Staining (Day 2)
    1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
    2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
    3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
    4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
    5. Wash with PBST for 3 times, 5 minutes each time.
     
    Mounting
    1. Mount the sample with an anti-fade mounting medium.
    2. Allow the slide to dry at room temperature overnight in the dark.
    3. Store the slide in a slide storage box at 4°C, protected from light.
     

    Datasheet & SDS

    生物学的記述

    Specificity
    Phospho-Estrogen Receptor α (Ser167) Antibody (Rabbit mAb) [D20F17] detects endogenous levels of total Estrogen Receptor α protein only when it is phosphorylated at Ser167.
    Uniprot ID
    P03372
    Clone
    D20F17
    Synonym(s)
    DKFZp686N23123, E2 receptor alpha, ER, ER-alpha, Era, ESR, ESR1, ESRA, Estradiol receptor, estrogen receptor alpha E1-N2-E2-1-2, ESTRR, NR3A1, Nuclear receptor subfamily 3 group A member 1, oestrogen receptor alpha
    Background
    Phospho–estrogen receptor α (Ser167) represents a ligand- and growth factor–regulated form of ERα, a steroid receptor family transcription factor that integrates estrogen signaling with multiple kinase cascades through its modular DNA-binding domain, ligand-binding domain, and N‑terminal AF‑1 activation region that contains Ser167 within a cluster of regulatory serines. The AF‑1 domain harbors Ser104, Ser106, Ser118, and Ser167, and phosphorylation at these residues modulates ERα transcriptional output by altering receptor conformation, chromatin association, and coactivator recruitment, with Ser167 acting as a key node for cross-talk between estrogen and kinase pathways such as mTOR/S6K1, MAPK/p90RSK, Akt, and IKKϵ. Kinases activated downstream of growth factor receptors and oncogenic signaling, including S6K1, RSK, Akt, and IKKϵ, directly phosphorylate Ser167, which enhances ERα-dependent transcriptional activity and supports estrogen-responsive gene expression even under conditions of low ligand, thereby promoting cell-cycle progression and proliferation in ERα-positive tumor cells. Site-specific modulation of Ser167 phosphorylation shapes the temporal pattern of ERα and coactivator complex recruitment to estrogen-responsive promoters and influences the spectrum of target genes that control growth, survival, migration, and invasion, so that Ser167 acts not only as a binary activation mark but also as a determinant of transcriptional programs linked to tumor behavior and therapeutic response. Phosphorylation of Ser167 correlates with activation of upstream MAPK and S6K1 pathways and with increased nuclear accumulation of phospho-ERα, highlighting its position as a downstream readout of mitogenic kinase activity and as a convergence point where growth factor and estrogen signals cooperate to maintain ERα-driven transcription. Clinical analyses of ERα-positive breast cancers show that detection of ERα phosphorylated on Ser167 associates with response to endocrine therapy and with improved post-relapse survival in metastatic settings, indicating that this modification marks tumors that retain functional ER signaling capacity even in the presence of endocrine agents. At the same time, persistent or kinase-driven Ser167 phosphorylation contributes to ligand-independent ERα activation and to resistance mechanisms against tamoxifen and other endocrine treatments, as growth factor–dependent phosphorylation sustains ERα target gene transcription despite receptor antagonism and links phospho-Ser167 status to poor prognosis in subsets of hormone-dependent malignancies, including breast and endometrial cancers.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください